HIGH SUSANNA GATTI

CIK 00016910051 companyWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001691005

Recent Transactions

34 trades

Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-09-18$34.41/sh−4,340→ 136,272 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-09-18$34.41/sh−4,636→ 131,636 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-09-11$31.89/sh−2,548→ 143,334 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-09-11$31.89/sh−2,722→ 140,612 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-08-19$46.00/sh−328→ 145,882 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-08-19$45.01/sh−2,582→ 146,210 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-06-24$35.33/sh−10,213→ 148,792 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-06-24$35.33/sh−10,163→ 148,792 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-06-24$5.54/sh+10,163→ 158,955 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-06-24$5.54/sh+10,213→ 159,005 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Stock option (right to buy)
2024-06-24−10,163→ 60,536 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Stock option (right to buy)
2024-06-24−10,213→ 60,486 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-06-21$35.01/sh−29,787→ 148,792 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-06-21$5.54/sh+29,787→ 178,579 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Stock option (right to buy)
2024-06-21−29,787→ 70,699 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-06-21$35.01/sh−29,787→ 148,792 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Stock option (right to buy)
2024-06-21−29,787→ 70,699 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-06-21$5.54/sh+29,787→ 178,579 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-06-12$5.54/sh+40,000→ 188,792 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-06-12$33.70/sh−13,964→ 148,792 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Stock option (right to buy)
2024-06-12−40,000→ 100,486 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-06-12$33.17/sh−26,036→ 162,756 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-06-11$31.23/sh−2,913→ 148,792 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-06-11$31.23/sh−2,357→ 151,705 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-06-10$30.24/sh−80,000→ 154,062 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-06-10$5.54/sh+80,000→ 234,062 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Stock option (right to buy)
2024-06-10−80,000→ 140,486 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-05-16$28.20/sh−2,249→ 154,551 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-05-16$28.59/sh−489→ 154,062 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-03-11$25.70/sh−2,292→ 156,800 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-03-08$26.66/sh−26,908→ 159,383 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-03-08$27.41/sh−291→ 159,092 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-03-07$25.85/sh−1,591→ 186,291 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2023-09-18$9.41/sh−2,672→ 104,544 total

Companies

Dyne Therapeutics, Inc.
Chief Operating Officer
$DYN

Recent Filings

Address

1560 TRAPELO ROAD

WALTHAM, MA, 02451

View on SEC.gov